BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

BioGaia

BioGaia AB conducts research, development and production operations based on biological systems that improve the health and increase the immunity to disease of both humans and animals. The company markets licenses, concepts and products in international markets.

BioGaia is publicly traded on the Swedish Stock exchange and has its head office in Stockholm, Sweden and a research laboratory in Raleigh, North Carolina, USA. Altogether the group occupies approximately 32 employees. BioGaia markets products through the following business units, situated in Stockholm and Lund, Sweden:

Animal Health, Functional Foods and HealthCare.


Contact Details:
6213 D Angus Drive
Raleigh
NC
27 617
United States of America
Tel:782 33 12
Fax:783 69 40
Email:info@biogaia.com
WWW:

www.biogaia.se/




Loading...

Recent Publications by BioGaia:

Removal of antibiotic resistance plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain L. reuteri DSM 17938.
The spread of antibiotic resistance in pathogens is primarily a...
12th August, 2008
Department of Microbiology, Swedish University of Agricultural Sciences, Appl Environ Microbiol. 2008 Aug 8.
DOI Direct Link
Safety of D(-)-lactic acid producing bacteria in the human infant.
The spread of antibiotic resistance in pathogens is primarily a...
15th March, 2006
Department of Research, BioGaia AB, Sweden. J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):489-92.

BioNews Results for BioGaia:

Swedish biotech company BioGaia AB signs licence agreement with Nestle
M2:  Aug 21 2008 12:21PM Matching: biogaia
Swedish biotech company BioGaia AB posts 1H operating profit of SEK12.6m
M2:  Aug 21 2008 12:22PM Matching: biogaia

BioGaia Patents:

US Patent No.Title
7374924 Use of selected lactic acid bacteria for reducing infantile colic
5413960 Antibiotic reuterin
5439678 Method for inhibiting microorganism growth
5458875 In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
5480641 Feed additive which consists of whey and Lactobacillus reuteri and a method of delivering Lactobacillus reuteri to the gastrointestinal tract

View more BioGaia patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 226 times since April 2007, the link to the organisation's website has been followed 34 times

Recent Search Terms used to find this page: BIOGAIA REUTERIN PATENT | J-Pediatr-Gastroenterol-Nutr. 2005 Oct 41 4 489-92 | J-Pediatr-Gastroenterol-Nutr. 2005 Oct 41 4 489-92 | Biogaia poultry | biogaia.com | biogaia.com | Biogaia poultry | Biogaia poultry | Biogaia Lund | biogaia | .

Search for more companies in Raleigh

Search for more companies in NC



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for BioGaia
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.